Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRN
3501
DELISTED
Veren
VRN
| $133K | ﹤0.01% |
18,698
+10,977
| +142% | +$86.1K |
|
3502
Seres Therapeutics
MCRB
$48M
| $132K | ﹤0.01% |
1,924
+992
| +106% | +$85.5K |
|
3503
Comp X International
CIX
$367M
| $131K | ﹤0.01% |
5,661
-180
| -3% | -$4.03K |
|
3504
Heritage Insurance Holdings
HRTG
$998M
| $131K | ﹤0.01% |
49,617
-9,018
| -15% | -$38.4K |
|
3505
OneSpan
OSPN
$607M
| $131K | ﹤0.01% |
11,036
+10,804
| +4,657% | +$142K |
|
3506
Stoke Therapeutics
STOK
$2.08B
| $131K | ﹤0.01% |
9,921
+5,236
| +112% | +$79.5K |
|
3507
Central Garden & Pet Co
CENT
$2.78B
| $130K | ﹤0.01% |
3,846
-6,009
| -61% | -$211K |
|
3508
Nokia
NOK
$52.3B
| $130K | ﹤0.01% |
28,143
-1,013,554
| -97% | -$5.06M |
|
3509
World Acceptance Corp
WRLD
$874M
| $130K | ﹤0.01% |
1,160
-2,169
| -65% | -$341K |
|
|
STRY
3510
DELISTED
Starry Group Holdings, Inc.
STRY
| $130K | ﹤0.01% |
31,613
-30,462
| -49% | -$224K |
|
|
EBTC
3511
DELISTED
Enterprise Bancorp
EBTC
| $129K | ﹤0.01% |
4,000
-1,037
| -21% | -$35.4K |
|
3512
iShares 7-10 Year Treasury Bond ETF
IEF
$47.2B
| $129K | ﹤0.01% |
1,258
-1
| -0.1% | -$103 |
|
3513
Magnite
MGNI
$3.61B
| $129K | ﹤0.01% |
14,561
-14,164
| -49% | -$152K |
|
|
VLTA
3514
DELISTED
Volta Inc.
VLTA
| $129K | ﹤0.01% |
99,433
+3,525
| +4% | +$7.86K |
|
|
NCTY
3515
The9 Ltd
NCTY
$67.7M
| $128K | ﹤0.01% |
7,600
| – | – |
|
|
DZSI
3516
DELISTED
DZS Inc. Common Stock
DZSI
| $128K | ﹤0.01% |
7,833
-1,605
| -17% | -$23.7K |
|
3517
Purple Innovation
PRPL
$42.2M
| $127K | ﹤0.01% |
1,670
+70
| +4% | +$8.13K |
|
|
HAYN
3518
DELISTED
Haynes International, Inc.
HAYN
| $127K | ﹤0.01% |
3,867
-6,095
| -61% | -$236K |
|
|
PRDS
3519
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $127K | ﹤0.01% |
41,553
-1,247
| -3% | -$7.61K |
|
3520
Amplitude
AMPL
$1.39B
| $126K | ﹤0.01% |
+8,856
| New | +$155K |
|
3521
The Honest Company
HNST
$599M
| $126K | ﹤0.01% |
42,833
-12,903
| -23% | -$46.6K |
|
3522
Motorcar Parts of America
MPAA
$262M
| $125K | ﹤0.01% |
9,577
-9,389
| -50% | -$140K |
|
3523
PennyMac Financial
PFSI
$4.01B
| $125K | ﹤0.01% |
2,865
+2,788
| +3,621% | +$132K |
|
3524
Sutro Biopharma
STRO
$421M
| $125K | ﹤0.01% |
2,384
-2,975
| -56% | -$166K |
|
|
CMLS
3525
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $125K | ﹤0.01% |
16,196
+927
| +6% | +$10.9K |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 560 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 560 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.